Zura Bio Ltd

Small-Cap Stocks Penny Stocks Biotech Stocks Healthcare Stocks

$4.80

+0.05 (+1.05%)

As of May 16, 1:59 AM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 13 93%

Hold 1 7%

Sell 0 0%

Price Target

Analyst Price Target +381.7% upside

Low Target $15.51

Average Target $23.12

High Target $31.84

Current Price $4.80

Current
$4.80

Target
$23.12

$15.51 $23.12 avg $31.84

Scenario Analysis

Bear Case

$15.51

223.1%

Low target

Base Case

$23.12

+381.7%

Avg target

Bull Case

$31.84

+563.3%

High target

Risk/Reward

2.5x

Favorable

Price in Context

52-Week High

$7.44

-35.5% from high

52-Week Low

$0.98

+389.8% from low

Target vs 52W High

$23.12

+210.8% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	75%	$257.58	+22.4%
AMGN Amgen Inc	Hold	44	48%	$190.87	-41.5%
GILD Gilead Sciences Inc	Strong Buy	39	79%	$362.68	+179.9%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	+0.3%
REGN Regeneron Pharmaceuticals	Strong Buy	38	79%	$76.80	-89.0%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-64.3%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-21.7%
BIIB Biogen Inc	Buy	43	56%	$91.45	-52.6%